SPOTLIGHT -
Slideshow
Author(s):
Patients with difficult conditions such as delusional parasitosis tend to resist the notion that a psychiatric problem underlies their symptoms.
Recovery as the Goal: Challenges in Schizophrenia Treatment
Blue Light Blockers: A Behavior Therapy for Mania
Breaking Down Barriers to Quality Care for Patients With Schizophrenia
Treating ‘Morally Objectionable’ Patients
Disappointing Data From Phase III CONNEX for Iclepertin in Addressing Cognition Impairment in Schizophrenia
Why We Need a New Class of Antidepressants